Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Shanghai - Delayed Quote CNY

Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS)

Compare
43.81
+0.86
+(2.00%)
At close: April 2 at 3:00:04 PM GMT+8
Loading Chart for 688131.SS
  • Previous Close 42.95
  • Open 42.95
  • Bid 43.81 x --
  • Ask 43.82 x --
  • Day's Range 42.83 - 44.46
  • 52 Week Range 17.94 - 48.39
  • Volume 3,814,586
  • Avg. Volume 2,869,283
  • Market Cap (intraday) 9.242B
  • Beta (5Y Monthly) 0.59
  • PE Ratio (TTM) 45.64
  • EPS (TTM) 0.96
  • Earnings Date --
  • Forward Dividend & Yield 0.08 (0.19%)
  • Ex-Dividend Date Oct 25, 2024
  • 1y Target Est --

Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. It offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

www.chemexpress.cn

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 688131.SS

View More

Performance Overview: 688131.SS

Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

688131.SS
22.72%
SSE Composite Index (000001.SS)
0.05%

1-Year Return

688131.SS
74.36%
SSE Composite Index (000001.SS)
8.95%

3-Year Return

688131.SS
25.96%
SSE Composite Index (000001.SS)
2.05%

5-Year Return

688131.SS
64.12%
SSE Composite Index (000001.SS)
20.48%

Compare To: 688131.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 688131.SS

View More

Valuation Measures

As of 4/2/2025
  • Market Cap

    9.24B

  • Enterprise Value

    9.82B

  • Trailing P/E

    45.64

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.05

  • Price/Book (mrq)

    3.21

  • Enterprise Value/Revenue

    4.33

  • Enterprise Value/EBITDA

    22.71

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.08%

  • Return on Assets (ttm)

    5.58%

  • Return on Equity (ttm)

    7.81%

  • Revenue (ttm)

    2.26B

  • Net Income Avi to Common (ttm)

    204.98M

  • Diluted EPS (ttm)

    0.96

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    497.45M

  • Total Debt/Equity (mrq)

    49.09%

  • Levered Free Cash Flow (ttm)

    102.1M

Research Analysis: 688131.SS

View More

People Also Watch